Diversifying clinical trials: Does presentation at gynecologic oncology tumor board increase equitable access to clinical trials for Black and LatinX patients?

Authors

Afryea Dunbar, LSU Health Sciences Center - New OrleansFollow
Fraya King, LSU Health Sciences Center - New Orleans
Madison Keller, LSU Health Sciences Center - New OrleansFollow
Yaseen Khan, LSU Health Sciences Center - New OrleansFollow
Amber Bardarson, LSU Health Sciences Center - New OrleansFollow
Amelia Jernigan, LSU Health Sciences Center - New OrleansFollow
Andrew Chapple, LSU Health Sciences Center - New OrleansFollow
Tara Castellano, LSU Health Sciences Center - New OrleansFollow
Navya Nair, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

9-22-2023

Publication Title

Gynecologic Oncology

Abstract

Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer, March 25 - 28, 2023, Tampa, FL

First Page

S259

Last Page

S260

Volume

176

Issue

Supplement 1

Comments

Abstract Number 2205

Recommended Citation

Dunbar, Afryea; King, Fraya; Keller, Madison; Khan, Yaseen; Bardarson, Amber; Jernigan, Amelia; Chapple, Andrew; Castellano, Tara; and Nair, Navya, "Diversifying clinical trials: Does presentation at gynecologic oncology tumor board increase equitable access to clinical trials for Black and LatinX patients?" (2023). School of Medicine Faculty Publications. 2416.
https://digitalscholar.lsuhsc.edu/som_facpubs/2416
10.1016/j.ygyno.2023.06.325